Incyte (INCY) EPS (Basic) (2010 - 2026)

Incyte has reported EPS (Basic) for 17 years, with the latest figure at $1.52 in Q1 2026.

• For the quarter ending Q1 2026, EPS (Basic) rose 85.37% year-over-year to $1.52; the trailing twelve-month figure through Mar 2026 stood at $7.29 (up 2413.79% YoY), and the FY2025 full-year result was $6.59, up 4018.75% from the prior year.
• EPS (Basic) for Q1 2026 stood at $1.52, up from $1.51 in the prior quarter.
• The five-year high for EPS (Basic) was $2.17 in Q3 2025, with the low at -$2.04 in Q2 2024.
• Historically, EPS (Basic) has averaged $0.74 across 5 years, with a median of $0.76 in 2023.
• The largest YoY upside for EPS (Basic) was 660.0% in 2024 against a maximum downside of 324.18% in 2024.
• Incyte's EPS (Basic) stood at $0.12 in 2022, then surged by 650.0% to $0.9 in 2023, then advanced by 6.67% to $0.96 in 2024, then jumped by 57.29% to $1.51 in 2025, then rose by 0.66% to $1.52 in 2026.
• The last three EPS (Basic) figures came in at $1.52 (Q1 2026), $1.51 (Q4 2025), and $2.17 (Q3 2025), per Business Quant data.